Famprya – a casualty of the inequity in Health Spending?

[Speaking in the Seanad during Statements on Availability of Certain Medication] The Minister is very familiar with the whole concept of health economics. I do not believe for one second that medicine can be practised in an economic vacuum. I understand that every decision made about a patient has an opportunity cost for another patient … Continue reading

Calling on the Minister to expand access to the anti-hepatitis-C drug, Sovaldi

14-05 John speaking 3

[Speaking in the Seanad during Order of Business] I propose an amendment to the Order of Business to ask the Minister for Health to come to the House to deal with a very urgent matter which I do not believe will wait for two weeks until we are back – namely, the exact timeline for … Continue reading

The need for the MS drug Famprya to remain funded by the State

[Speaking in the Seanad during Order of Business] I would be grateful if the Deputy Leader could find out something for me. I was very distressed to find out from a patient, in correspondence I received this morning, that the drug fampyra, which has been shown to improve the ability of patients with multiple sclerosis … Continue reading

Our lives have more value than these health system cost controls

Published in Sunday Independent, 1 April, 2007 MANY doctors have reservations about the most recent health service bureaucracy, the Health Information Quality Authority (HIQA), which was unveiled last the week – incidentally by the same PR company that represents the nursing homes which it will inspect. The agency, initiated by Micheal Martin when he was … Continue reading